The first stop for professional medicines advice

Patient Group Directions

139 results

RelevanceNewest firstOldest firstTitle
Applied filters

Medicines Shortages and Patient Group Directions

16 December 2019This article outlines how PGDs can be managed to allow for their continued use in cases of medicines shortages.

Auditing Patient Group Directions

14 September 2020SPS have developed a template audit tool to support organisations in auditing aspects of PGD development and use.

Inclusion of dose ranges in a single Patient Group Direction

9 September 2020The below summarises the considerations required if a single PGD is to include a range of doses.

Off-label or unlicensed product use under HMR 2012 exemptions

8 January 2020The below summary details the legal position regarding the sale, supply or administration of off-label/unlicensed products under Schedule 17 of the HMR 2012

Authorising Independent Healthcare Provider (IHP) PGDs

21 September 2020This article outlines the considerations needed when NHS or local authorities commission services using PGDs from independent healthcare providers

Delegating PGD authorisation by a Local Authority

7 March 2022This summary explains why it is not permitted for a Local Authority to delegate the authorisation of PGDs using a Section 75 partnership agreement.

UK Health Security Agency (UKHSA) PGD Templates

14 September 2020PGD templates are developed by UKHSA for a variety of clinical scenarios. Links are provided as well as a summary of authorisation and implementation processes.

Managing PGDs following organisational change

3 February 2022Advice on the management of PGDs when there are organisational changes to ensure continuation of safe care and overarching good governance.

NHS prescription charges for PGDs or HMR 2012 exemptions

16 November 2021This article summarises the position regarding the levying of prescription charges for medicines supplied under a PGD.

PGD use in services provided by multiple organisations

14 July 2020This article outlines the principles to be considered when PGDs are used in the provision of medicines/vaccines in services provided by multiple organisations.